Valeant Pharmaceuticals International Inc (NYSE:VRX)

198.62
Delayed Data
As of Mar 31
 -2.76 / -1.37%
Today’s Change
106.00
Today|||52-Week Range
206.84
+38.79%
Year-to-Date

Today’s Trading

Previous close201.38
Today’s open200.65
Day’s range197.55 - 201.49
Volume1,542,068
Average volume (3 months)3,153,847
Market cap$67.2B
Dividend yield--
Data as of 4:02pm ET, 03/31/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+26.15%
Earnings growth (next 5 years)+26.30%
Revenue growth (last year)+43.22%
P/E ratio74.3
Price/Sales5.83
Price/Book12.68

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories-0.75-1.59%
LLYEli Lilly and Co-1.22-1.65%
SHPGShire-2.69-1.11%
AZNAstraZeneca-1.51-2.16%
Data as of 4:06pm ET, 03/31/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)$2.30
Annual revenue (last year)$8.3B
Annual profit (last year)$913.5M
Net profit margin11.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer, Director &
Executive VP
Howard Bradley Schiller
Corporate headquarters
Laval, Quebec

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account